v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 8,430,946 $ 63,741
Prepaid expenses 115,386 94,070
Total current assets 8,546,332 157,811
Other assets:    
Licenses 2,251,134 2,251,134
Patents 48,420 48,420
Total other assets 2,299,554 2,299,554
Total assets 10,845,886 2,457,365
Current liabilities:    
Accounts payable 12,631 63,686
Accrued expenses 50,331 912,095
Notes payable 240,753
Total current liabilities 62,962 1,247,534
Warrant liability 132,447 24,486
Total liabilities 195,409 1,272,020
Commitments and contingencies (Note 10)
STOCKHOLDERS’ EQUITY    
Preferred stock, par value $0.0001, 100,000,000 shares authorized; 500 and 0 issued and outstanding as of June 30, 2025 and December 31, 2024, respectively
Common stock, par value $0.0001, 1,000,000,000 shares authorized; 52,703,070 and 27,080,915 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively 5,270 2,708
Additional paid-in capital 27,535,219 11,745,436
Accumulated deficit (16,890,012) (10,562,799)
Total stockholders’ equity 10,650,477 1,185,345
Total liabilities and stockholders’ equity 10,845,886 2,457,365
Related Party    
Current liabilities:    
Notes payable to related parties $ 31,000